Optimization of parameters for the quantitative surface-enhanced raman scattering detection of mephedrone using a fractional factorial design and a portable raman spectrometer

Analytical Chemistry

Volumn 85, Issue 2, 2013, Pages 923-931

  Mabbott, Samuel ^a   Correa, Elon ^a   Cowcher, David P ^a   Allwood, J William ^a   Goodacre, Royston ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATING AGENTS; ANALYTICAL METHOD; DETECTION LIMITS; FRACTIONAL FACTORIAL DESIGNS; IN-FIELD; LIMIT OF DETECTION; OPTIMIZATION OF PARAMETERS; OPTIMIZATION STRATEGY; RAMAN PEAK; RAMAN SPECTROMETERS; RAMAN SYSTEMS; RELATIVE STANDARD DEVIATIONS; REPRODUCIBILITIES; SIGNAL OPTIMIZATION; SURFACE ENHANCED RAMAN SCATTERING (SERS);

DESIGN; EXPERIMENTS; NANOPARTICLES; OPTIMIZATION; SALTS; SURFACE SCATTERING;

SIGNAL DETECTION;

4' METHYLMETHCATHINONE; DRUG DERIVATIVE; GOLD; METAL NANOPARTICLE; METHAMPHETAMINE; SILVER;

ARTICLE; CHEMISTRY; PH; RAMAN SPECTROMETRY; SURFACE PROPERTY;

GOLD; HYDROGEN-ION CONCENTRATION; METAL NANOPARTICLES; METHAMPHETAMINE; SILVER; SPECTRUM ANALYSIS, RAMAN; SURFACE PROPERTIES;

EID: 84872549596     PISSN: 00032700     EISSN: 15206882     Source Type: Journal    
DOI: 10.1021/ac302542r     Document Type: Article

References (60)

1. Brunt, T. M.; Poortman, A.; Miesink, R. J.; van den Brink., W. J. Psychopharmacol. 2011, 25, 1543-1547
2. Schmidt, M. M.; Sharma, A.; Schifano, F.; Feinmann, C. Forensic Sci. Int. 2010, 206, 1-3
3. Hillebrand, J.; Olszewski, D.; Sedefov, R. Subst. Use Misuse 2010, 45, 330-340
4. Sare, J. Br. Med. J. 2011, 342.
5. Davey, Z.; Corazza, O.; Schifano, F.; Deluca, P. Drugs Alcohol Today 2010, 10, 24-28
6. Forsyth, A. J. Int. J. Drug Policy 2012, 23, 198-209
7. Measham, F.; Moore, K.; Newcombe, R.; Welch, Z. Drugs Alcohol Today 2010, 10, 14-21
8. Van Hout, M. C.; Brennan, R. Drugs: Education, Prevention & Policy 2011, 18, 371-381
9. Ramsey, J.; Dargan, P. I.; Smyllie, M.; Davies, S.; Button, J.; Holt, D. W.; Wood, D. M. Q. J. Med. 2010, 103, 777-783
10. Newcombe, R. Mephedrone: the use of mephedrone (M-cat, Meow) in Middlesborough; Publications & Research: Manchester, pp 1-16, 2009.
11. Winstock, A. R.; Marsden, J.; Mitcheson, L. Br. Med. J. 2010, 340, c1605
12. Schifano, F.; Albanese, A.; Fergus, S.; Stair, J. L.; Deluca, P.; Corazza, O. Psychopharmacology 2011, 214, 593-602
13. Vardakou, I.; Pistos, C.; Spiliopoulou, C. Toxicol. Lett. 2011, 201, 191-195
14. De Paoli, G.; Brandt, S. D.; Pounder, D. J. Br. Med. J. 2011, 342, 1629
15. Van Hout, M. C.; Bingham, T. Int. J. Drug Policy 2012, 23, 188-197
16. Gibbons, S. Clin. Toxicol. 2012, 50, 15-24
17. Liseka, R.; Xua, W.; Yuvashevaa, E.; Chiua, Y.-T.; Reitzb, A. B; Lui-Chena, L.-Y.; Rawsla, S. M. Drug Alcohol Depend. 2012, 126, 257-262
18. Fass, J. A.; Fass, A. D.; Garcia, A. S. Ann. Pharmacother. 2012, 46
19. Wood, D. M.; Greene, S. L.; Dargan, P. I. Emerg. Med. J. 2011, 28, 280-282
20. Kalix, P. J. Ethnopharmacology 1991, 32, 201-208
21. Sammler, E. M.; Foley, P. L.; Lauder, G. D.; Wilson, S. J.; Goudie, A. R.; O'Riordan, J. I. Lancet 2010, 376, 742
22. Meyer, M. R.; Wilhelm, J.; Peters, F. T.; Maurer, H. H. Anal. Bioanal. Chem. 2010, 397, 1225-1233
23. Saem de Burnaga Sanchez, J. Bull. Soc. Chim. Fr. 1929, 45, 284-286
24. Archer, R. P. Forensic Sci. Int. 2009, 185, 10-20
25. ACMD (Advisory Council on the Misuse of Drugs). Consideration of the cathinones. http://www.homeoffice.gov.uk/publications (accessed Aug 10, 2012).
26. Europol-EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). http://www.emcdda.europa.eu (accessed Aug 12, 2012).
27. Kehr, J.; Ichinose, F.; Yoshitake, S.; Goiny, M.; Sievertsson, T.; Nyberg, F.; Yoshitake, T. J Pharmacol. 2011, 164, 1949-1958
28. Martinez-Clemente, J.; Escubedo, E.; Pubill, D.; Camarasa, J. Eur. Neuropsychopharm. 2012, 22, 231-236
29. Torrance, H.; Cooper, G. Forensic Sci. Int. 2010, 202, 62-63
30. Lusthof, K. J.; Oosting, R.; Maes, A.; Verschraagen., M.; Dijkhuizen, A.; Sprong, A. G. A. Forensic Sci. Int. 2011, 206, 93-95
31. James., D.; Adams, R. D.; Spears, R.; Cooper, G.; Lupton, D. J.; Thompson, P.; Thomas, S. H. Emerg. Med. J. 2010, 28, 686-689
32. Nicholson, P. J.; Quinn, M. J.; Dodd, J. D. Heart 2010, 96, 2051-2052
33. The Misuse of Drugs (Amendment) (England, Wales and Scotland); Regulations 2010 No. 1144. Office of Public Sector Information. http://www.legislation.gov.uk/uksi/2010/1144/ (accessed July 15, 2012).
34. Winstock, A.; Mitcheson, L.; Marsden, J. Lancet 2010, 376, 1537
35. Power, J. D.; McGlynn, P.; Clarke, K.; McDermott, S. D.; Kavanagh, P.; O'Brien, J. Forensic Sci. Int. 2011, 212, 6-12
36. Camilleri, A.; Johnston, M. R.; Brennan, M.; Davis, S.; Caldicott, D. G. E. Forenisc Sci. Int. 2010, 197, 59-66
37. Gibbons, S.; Zloh, M. Bioorg. Med. Chem. Lett. 2010, 20, 4135-4139
38. Santali, E. Y.; Cadogan, A.-K.; Daeid, N. N.; Savage, K. A.; Sutcliffe, O. B. J. Pharm. Biomed. 2011, 56, 246-255
39. Deruiter, L.; Hayes., L.; Valaer, A.; Clark, C. R.; Noggle, F. T. J. Chromatogr. Sci. 1994, 32, 552-564
40. Stewart, S. P.; Bell, S. E. J.; Fletcher, N. C.; Bouazzaoui, S.; Hoa, Y. C.; Speers, S. J.; Peters, K. L. Anal. Chim. Acta 2012, 711, 1-6
41. Nycz, J. E.; Malecki, G.; Zawiazalec, M.; Pazdziorek, T. J. Mol. Struct. 2011, 1002, 10-18
42. Shah, S. A. B.; Deshmukha, N. I. K.; Barker, J.; Petrocz, A.; Cross, P.; Archer, R.; Naughton, D. P. J. Pharm. Biomed. 2012, 61, 64-69
43. Martin, M.; Muller, J. F.; Turner, K.; Duez, M.; Cirimele, V. Forensic Sci. Int. 2012, 218, 44-48
44. Moskovits, M. Surface-Enhanced Raman Spectroscopy: A Brief Perspective. In Surface-Enhanced Raman Scattering-Physics and Applications; Kneipp, K., Ed.; Springer-Verlag: Berlin, Germany, 2006, pp 1-18.
45. Campion, A.; Kambhampati, P. Chem. Soc. Rev. 1998, 27, 241-250
46. Sulk, R. A.; Corcoran., R. C.; Carron, K. T. J. Appl. Spectrosc. 1999, 53, 954-959
47. Sagmuller, B.; Schwarze, B.; Brehm, G.; Schneider, S. Analyst 2001, 126, 2066-2071
48. Faulds, K.; Smith, W. E.; Graham, D.; Lacey, R. J. Analyst 2002, 127, 282-286
49. Bailey, R. A. Design of Comparative Experiments. Cambridge Series in Statistical and Probabilistic Mathematics; Cambridge University Press: Cambridge, U.K., 2008.
50. Turkevich, J.; Stevenson, P. C.; Hillier, J. Discuss. Faraday Soc. 1951, 11, 55-75
51. Lee, P. C.; Meisel, D. J. Phys. Chem. 1982, 86, 3391-3395
52. Mukerjee, R.; Wu, C. F. J. A Modern Theory of Factorial Design. Springer Series in Statistics; Springer: New York, 2006.
53. Quinn, G. P.; Keough, M. J. Experimental Design and Data Analysis for Biologists; Cambridge University Press: Cambridge, U.K., 2002.
54. Le Ru, E. C.; Etchegoin, P. Principles of Surface-Enhanced Raman Spectroscopy and Related Plasmonic Effects; Elsevier: Oxford, U.K., 2009.
55. Martens, H.; Nielsen, P. J.; Engelsen, S. B. Anal. Chem. 2003, 75, 394-404
56. Vinzi, E. V.; Chin, V. W.; Henseler, J.; Wang, H. Handbook of Partial Least Squares; Springer: New York, 2010.
57. Eilers, P. H. C.; Boelens, H. F. M. Baseline correction with asymmetric least squares smoothing; Leiden University Medical Centre Report, 2005.
58. MacDougall, D.; Crummett, W. B. Anal. Chem. 1980, 52, 2242-2249
59. Sumnall, H.; Wooding, O. Mephedrone: an update on current knowledge. Centre for Public Health, Liverpool John Moores University. http://www. drugsandalcohol.ie/12762/ (accessed Aug 19, 2010).
60. Socrates, G. Infrared and Raman Characteristic Group Frequencies: Tables and Charts, 3 rd ed.; Wiley: New York, 2001.